NEW YORK — Chinese single-cell genomics firm Analytical Biosciences (ABio) said on Monday that it has partnered with BioMap to develop commercial analytical and artificial intelligence-based computing platforms for single-cell genomics.
The deal includes an undisclosed strategic investment from BioMap, an AI-powered life sciences company founded by Baidu executives. Additional terms were not disclosed.
"Multi-omics data has become a cornerstone for future life science research," BioMap CEO Wei Liu said in a statement. "As China's first computational life science platform company, we look forward to working with Analytical Biosciences to jointly accelerate the research and development of innovative precision medicine products."
Last December, Analytical Sciences closed an A+ financing round of undisclosed size that was led by SoftBank China Venture, with contributions from IDG Capital and Apricot Venture.
The Beijing-based company said it has already established a database of integrated and curated single-cell genomics data and developed core analytical and visualization tools.